Endothelial progenitor cells: precursors for angiogenesis.
The presence of endothelial progenitor cells has been demonstrated in the bone marrow and systemic circulation of adults, thus raising the possibility of a novel strategy to induce therapeutic angiogenesis for ischemic arterial disease. Successful incorporation into sites of actively occurring angiogenesis in numerous animal models has accelerated the enthusiasm for exploiting their therapeutic capacity in humans and has led to the recent use of putative endothelial precursor cells in phase I feasibility and safety studies. However, key biological issues remain ill defined. The relative contribution of these cells to postnatal physiological and pathological neovascularization has not been fully characterized. Furthermore, the molecular phenotype of the putative endothelial progenitor cell and the processes leading to their mobilization from the bone marrow and homing to sites of angiogenesis have yet to be elucidated. This review addresses these fundamental issues that warrant further basic investigation before the full therapeutic potential of these cells can be achieved within appropriate target patients.
Khurana
Rohit
R
Section of Cardiology and Angiogenesis Research Center, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH, USA.
Simons
Michael
M
D000328:Adult; D000818:Animals; D001853:Bone Marrow / Q000502:physiology; D003327:Coronary Disease / Q000503:physiopathology / Q000628:therapy; D004727:Endothelium / Q000502:physiology*; D005121:Extremities / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000503:physiopathology / Q000628:therapy; D018919:Neovascularization, Physiologic / Q000502:physiology*; D010641:Phenotype; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000502:physiology*